Nicole Pinto
Papers
1
Total Citations
15
H-Index
1
About
Nicole Pinto’s research focuses on head and neck squamous cell carcinoma (HNSCC), with a particular emphasis on understanding the differential biology of human papillomavirus (HPV)-positive and HPV-negative tumors. Her major contribution is a landmark 2018 high-throughput drug screening study that systematically identified therapeutic agents with preferential activity in HPV-positive versus HPV-negative HNSCC cell lines. This work, which has garnered 15 citations, provided critical insights into how viral status influences treatment response, offering a roadmap for more personalized therapeutic strategies in HNSCC. By demonstrating that certain compounds exhibit selective cytotoxicity based on HPV status, Pinto’s research has directly informed the development of targeted therapies and improved preclinical models for this heterogeneous disease. Her collaborative approach, working across multiple institutions and with experts in virology and drug discovery, underscores her ability to translate complex biological questions into actionable clinical hypotheses. Nicole Pinto’s work is foundational for researchers and clinicians seeking to exploit viral oncogenesis for precision oncology in head and neck cancers.
Research Focus
Key Achievements
Top Papers
- 1